Chinese Journal of New Drugs Articles

Articles>Articles Overview

1Analysis of competition and collaboration of global organoid researchCHEN Juan, LONG Jun-yu, LI Zhuo-ting, PAN Li-zi, OUYANG Zhao-lian673-683

2Analysis of the main technological pathways in the organoid field based on patent citation networksZHANG Ting, CHEN Juan, LU Yan, XU Dong-zi, OUYANG Zhao-lian684-692

3Clinical safety research and considerations of human respiratory syncytial virus vaccineLIU Lin-yu, LU Shuang693-698

4Current research status and future application prospects of organ-on-a-chip technology in pharmacokineticsLI Yi-zhi, SHEN Shao-lei, WANG Hui-hao, WANG Jun-long, LIU Li699-705

5Exploring the mechanism of anti-cholestasis of Chinese medicine based on farnesol X receptorTANG Yin-pei, ZHU Zheng-wang, WANG Lin-lin, ZHAO Jing-han, WANG Bing, ZHU Ping-sheng706-712

6Research progress of chitosan as carriers of nucleic acid in gene therapyLI Hua-an, LI Zhi-yang, LIN Bo-han, LI Han-qi, WEN Ding-sheng, WEN Lu, CHEN Gang713-719

7Clinical research progress on Claudin 18.2 antibody-drug conjugatesLIAN Xiao-tong, LEI Yu720-726

8The development of the clinical efficacy evaluation scale for phlegm syndromeLÜ Xing, LIU Wen-na, WANG Jian-xin, ZHANG Yu, GAO Rui727-733

9Clinical adaptability assessment of the clinical efficacy evaluation scale for phlegm syndromeLÜ Xing, LIU Wen-na, WANG Jian-xin, ZHANG Yu, GAO Rui734-740

10Practice and experience in the management of clinical trial pharmacy at an oncology hospitalWANG Zhao-cong, YANG Yang, ZHANG Feng, XU Fang, LI Tian-en, WEI Xue-yan, HU Zhe, CHEN Jian741-746

11Analysis of the chemical components and mechanism of Xianling Gubao Capsules based on UHPLC Q-Exactive Orbitrap-MS combined with network pharmacologyCHENG Xue-yi, LIU Wen, CHEN Mei, LU Yuan, JIN Yang, LI Yong-jun747-760

12Preparation and in vitro evaluation of co-loaded nanostructured lipid carriers for methotrexate and cucurbitacin BLI Hao, BAO Ting-qi, HUANG Xin-yi, ZHOU Jian-wen, MIAO Wen-kai, WU Li-hong, WANG Zi-xun, CAO Li-xin, HAN Cui-yan761-770

13The synthesis,content determination and stability study of a β-carboline-cinnamic acid skeleton compound B4GUAN Li, CHEN Jia-xin, SONG Peng-fei, ZHAO Hui-ru, XIA Yan-xin, ZHANG Sheng-jie, LI Wei-ze771-777

14A systematic review of the cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibitors in the treatment of cardiovascular diseasesSUN Ling-yao, WANG Wen-shan, WANG Xin-ru, YUAN Fang-zhe, GU Yu-qi, TAN Yu-jie, TIAN Lei778-784